ITC Nexus, a provider of diagnostic solutions, has appointed John Sperzel as new chief executive officer (CEO).
Sperzel previously served as president of Axis-Shield, a provider of Point-of-Care immunoassay systems for diabetes, infection and cardiovascular disease.
He also served various positions in Bayer Diagnostics, Instrumentation Laboratory and Boehringer Mannheim Diagnostics (Roche).
He attained experience in various large and small companies, with substantial in Point-of-Care coagulation and critical care/blood gas testing.